China
· Delayed Price · Currency is CNY China National Accord Medicines Corporation Statistics
Total Valuation
China National Accord Medicines Corporation has a market cap or net worth of CNY 14.51 billion. The enterprise value is 19.86 billion.
| Market Cap | 14.51B |
| Enterprise Value | 19.86B |
Important Dates
The next estimated earnings date is Friday, October 25, 2024.
| Earnings Date | Oct 25, 2024 |
| Ex-Dividend Date | Jun 25, 2024 |
Share Statistics
China National Accord Medicines Corporation has 556.57 million shares outstanding. The number of shares has decreased by -0.21% in one year.
| Shares Outstanding | 556.57M |
| Shares Change (YoY) | -0.21% |
| Shares Change (QoQ) | -0.20% |
| Owned by Insiders (%) | 0.00% |
| Owned by Institutions (%) | 17.25% |
| Float | 237.64M |
Valuation Ratios
The trailing PE ratio is 10.28 and the forward PE ratio is 11.74. China National Accord Medicines Corporation's PEG ratio is 2.35.
| PE Ratio | 10.28 |
| Forward PE | 11.74 |
| PS Ratio | 0.21 |
| PB Ratio | 0.87 |
| P/FCF Ratio | 7.50 |
| PEG Ratio | 2.35 |
Enterprise Valuation
The stock's EV/EBITDA ratio is 5.70, with an EV/FCF ratio of 9.58.
| EV / Earnings | 13.13 |
| EV / Sales | 0.27 |
| EV / EBITDA | 5.70 |
| EV / EBIT | 9.86 |
| EV / FCF | 9.58 |
Financial Position
The company has a current ratio of 1.44, with a Debt / Equity ratio of 0.36.
| Current Ratio | 1.44 |
| Quick Ratio | 1.11 |
| Debt / Equity | 0.36 |
| Debt / EBITDA | 2.23 |
| Debt / FCF | 3.76 |
| Interest Coverage | 7.42 |
Financial Efficiency
Return on equity (ROE) is 8.20% and return on invested capital (ROIC) is 4.47%.
| Return on Equity (ROE) | 8.20% |
| Return on Assets (ROA) | 2.48% |
| Return on Capital (ROIC) | 4.47% |
| Revenue Per Employee | 1.90M |
| Profits Per Employee | 38,340 |
| Employee Count | 39,449 |
| Asset Turnover | 1.48 |
| Inventory Turnover | 7.83 |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +1.08% in the last 52 weeks. The beta is 0.40, so China National Accord Medicines Corporation's price volatility has been lower than the market average.
| Beta (5Y) | 0.40 |
| 52-Week Price Change | +1.08% |
| 50-Day Moving Average | 27.35 |
| 200-Day Moving Average | 31.04 |
| Relative Strength Index (RSI) | 59.98 |
| Average Volume (20 Days) | 6,156,061 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, China National Accord Medicines Corporation had revenue of CNY 74.88 billion and earned 1.51 billion in profits. Earnings per share was 2.72.
| Revenue | 74.88B |
| Gross Profit | 8.69B |
| Operating Income | 2.01B |
| Pretax Income | 2.14B |
| Net Income | 1.51B |
| EBITDA | 2.22B |
| EBIT | 2.01B |
| Earnings Per Share (EPS) | 2.72 |
Balance Sheet
The company has 6.01 billion in cash and 7.79 billion in debt, giving a net cash position of -1.78 billion or -3.20 per share.
| Cash & Cash Equivalents | 6.01B |
| Total Debt | 7.79B |
| Net Cash | -1.78B |
| Net Cash Per Share | -3.20 |
| Equity (Book Value) | 21.35B |
| Book Value Per Share | 31.95 |
| Working Capital | 12.22B |
Cash Flow
In the last 12 months, operating cash flow was 2.38 billion and capital expenditures -306.96 million, giving a free cash flow of 2.07 billion.
| Operating Cash Flow | 2.38B |
| Capital Expenditures | -306.96M |
| Free Cash Flow | 2.07B |
| FCF Per Share | 3.73 |
Margins
Gross margin is 11.61%, with operating and profit margins of 2.69% and 2.02%.
| Gross Margin | 11.61% |
| Operating Margin | 2.69% |
| Pretax Margin | 2.86% |
| Profit Margin | 2.02% |
| EBITDA Margin | 2.96% |
| EBIT Margin | 2.69% |
| FCF Margin | 2.77% |
Dividends & Yields
This stock pays an annual dividend of 0.68, which amounts to a dividend yield of 2.33%.
| Dividend Per Share | 0.68 |
| Dividend Yield | 2.33% |
| Dividend Growth (YoY) | -15.00% |
| Years of Dividend Growth | 1 |
| Payout Ratio | 36.97% |
| Buyback Yield | 0.21% |
| Shareholder Yield | 2.54% |
| Earnings Yield | 9.73% |
| FCF Yield | 13.33% |
Stock Splits
The last stock split was on June 1, 2023. It was a forward split with a ratio of 1.3.
| Last Split Date | Jun 1, 2023 |
| Split Type | Forward |
| Split Ratio | 1.3 |
Scores
China National Accord Medicines Corporation has an Altman Z-Score of 2.56. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | 2.56 |
| Piotroski F-Score | n/a |